Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 1272

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 1272
---
7. In addition, on January 29, 2017, our Board of Directors approved the Stock Option
Plan Israel Grantees Sub-Plan. The 2017 Equity Incentive Plan initially authorized the issuance of up to 667 shares of common stock
under the plan and the 2017 Consultant Equity Incentive Plan initially authorized the issuance of up to 1,000 shares of common stock
under the plan.

55

On
February 12, 2018, our stockholders approved an amendment to the 2017 Consultant Equity Incentive Plan to increase the maximum number
of shares of our common stock available for issuance under the plan from 1,000 to 1,500. On July 3, 2018, our stockholders approved
an amendment to the 2017 Equity Incentive Plan to increase the maximum number of shares of our common stock available for issuance under
the plan from 667 to 1,000 and an amendment to the 2017 Consultant Equity Incentive Plan to increase the maximum number of shares of
our common stock available for issuance under the plan from 1,500  to 2,334.

On
May 25, 2020, our Board reduced the exercise price of outstanding options of our employees and directors for the purchase of an aggregate
of 17,530 of our common stock (with exercise prices ranging between $3,630 and $1,830) to $208.0 per share, and extended the term of
the foregoing options for an additional one year from the original date of expiration.

On
August 10, 2020, our stockholders approved an increase in the shares available for issuance under the 2017 Equity Incentive Plan from
1,000 to 7,250 shares, and a decrease of the numbers of shares available for issuance under the 2017 Consultant Incentive Plan to 1,084
shares from 2,334 shares.

On
December 30, 2021, our stockholders approved an increase in the shares available for issuance under the 2017 Equity Incentive Plan from
7,250 shares to 28,850 shares.

On
December 7, 2022, our stockholders approved an increase in the shares available for issuance under the 2017 Equity Plan from 28,850
shares to 36,125 shares.

On
December 27, 2023, our stockholders approved an increase in